ANN ARBOR, MI – September 26, 2019 – Ripple Science, a SaaS company accelerating clinical research, has been selected to present at Renaissance Venture Capital’s fifth annual UnDemo Day. The UnDemo day event brings together Michigan’s top startups and technologies for an informal get together with venture capital funds and other Renaissance partners. Ripple Science CEO, Peter Falzon, shared, “UnDemo day provides access to a wider group of investors than Ripple has had in the past. The opportunity to speak one-on-one with multiple investors on the same day is timely as Ripple gears up to raise our next round of capital now that we have 100 customers, product market validation, and sales are ramping.” This year’s UnDemo day will be held on October 2 in Detroit’s Ford Field.
About Ripple Science: Ripple Science accelerates clinical research with its secure, HIPAA-compliant suite of tools. By adapting sales and marketing automation to the process of patient recruitment, Ripple helps our customers recruit more participants, faster and reduces patients lost to follow-up.
Ripple Science’s flagship product, Ripple, is currently being used by research investigators at more than 100 academic and research centers around the world, including Johns Hopkins University, Pennsylvania State University, University of California Los Angeles, the Brain Research Foundation Canada, University of East Anglia (UK), Cognito Therapeutics (Boston, MA) and the University of Michigan.